Transactions

Enterprise Therapeutics Ltd’s sale to Roche Group, and spin off of ENaC assets to shareholders

Date Announced:
10/07/2020

client:
Enterprise Therapeutics Ltd

Status:
Closed – 10/07/2020

Value:
Undisclosed